Non-self recognition by monocytes initiates allograft rejection

Journal of Clinical Investigation

Volumn 124, Issue 8, 2014, Pages 3579-3589

  Oberbarnscheidt, Martin H ^a   Zeng, Qiang ^a   Li, Qi ^a   Dai, Hehua ^a   Williams, Amanda L ^a   Shlomchik, Warren D ^b   Rothstein, David M ^a   Lakkis, Fadi G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; ALLOANTIGEN; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CARDIAC GRAFT REJECTION; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; FEMALE; HEART TRANSPLANTATION; IMMUNE RESPONSE; INNATE IMMUNITY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ALLOGRAFT; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DEFICIENCY; DENDRITIC CELL; GENETICS; GRAFT REJECTION; IMMUNOLOGY; ISOGRAFT; KIDNEY TRANSPLANTATION; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; NONOBESE DIABETIC MOUSE; T LYMPHOCYTE; TIME; TRANSGENIC MOUSE;

ADAPTIVE IMMUNITY; ALLOGRAFTS; ANIMALS; B-LYMPHOCYTES; CARRIER PROTEINS; DENDRITIC CELLS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNITY, INNATE; ISOANTIGENS; ISOGRAFTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TIME FACTORS;

EID: 84905457496     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI74370     Document Type: Article

References (45)

1. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 1989;54(pt 1):1-13.
2. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010;327(5963):291-295.
3. Klein J. Biology of the Mouse Histocompatibility-2 Complex. New York, Heidelberg, Berlin: Springer-Verlag; 1975:521-536.
4. Hildemann WH, Thoenes GH. Immunological responses of Pacific hagfish. I. Skin transplantation immunity. Transplantation. 1969;7(6):506-521.
5. Sykes M, Wood K, Sachs DH. In: Paul WE, ed. Fundamental Immunology. Philadelphia, Pennsylvania, USA: Woleters Kluwer/Lippincott Williams & Wilkins; 2008:1426-1488.
6. Herzenberg L, Bianchi DW, Schroder J, Cann H, Iverson M. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescenceactivated cell sorting. Proc Natl Acad Sci U S A. 1979;76(3):1453-1457.
7. Bonney EA, Matzinger P. The maternal immune system's interaction with circulating fetal cells. J Immunol. 1997;158(1):40-47.
8. Pearse AM, Swift K. Allograft theory: transmission of devil facial-tumour disease. Nature. 2006;439(7076):549.
9. Murgia C, Pritchard J, Kim S, Fassati A, Weiss R. Clonal origin and evolution of a transmissible cancer. Cell. 2006;126(3):477-487.
10. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 1999;5(11):1249-1255.
11. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol. 2008;8(4):279-289.
12. Iyer SS, et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A. 2009;106(48):20388- 20393.
13. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003;425(6957):516-521.
14. Shi Y, Galusha SA, Rock KL. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J Immunol. 2006;176(7):3905-3908.
15. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol. 2010;28:367-388.
16. Goldstein DR, Tesar BM, Akira S, Lakkis FG. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest. 2003;111(10):1571-1578.
17. Tesar BM, Zhang J, Li Q, Goldstein DR. TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll-like receptor signal adaptor protein. Am J Transplant. 2004;4(9):1429-1439.
18. McKay D, Shigeoka A, Rubinstein M, Surh C, Sprent J. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol. 2006;36(8):1994-2002.
19. Hutton MJ, Westwell-Roper C, Soukhatcheva G, Plesner A, Dutz JP, Verchere CB. Islet allograft rejection is independent of toll-like receptor signaling in mice. Transplantation. 2009;88(9):1075-1080.
20. Li H, et al. Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells. J Immunol. 2011;186(1):230-241.
21. Bingaman AW, et al. Vigorous allograft rejection in the absence of danger. J Immunol. 2000;164(6):3065-3071.
22. Anderson C, Carroll J, Gallucci S, Ridge J, Cheever A, Matzinger P. Testing time-, ignorance-, and danger-based models of tolerance. J Immunol. 2001;166(6):3663-3671.
23. Anderson CC, Matzinger P. Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat Med. 2001;7(1):80-87.
24. Chan WF, Perez-Diez A, Razavy H, Anderson CC. The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits. Biol Direct. 2007;2:10.
25. + T cells. J Immunol. 2010;184(12):6649-6657.
26. Zecher D, van Rooijen N, Rothstein D, Shlomchik W, Lakkis F. An innate response to allogeneic nonself mediated by monocytes. J Immunol. 2009;183(12):7810-7816.
27. Auffray C, Sieweke M, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009;27:669-692.
28. Jung S, et al. Analysis of fractalkine receptor CX (3) CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol. 2000;20(11):4106-4114.
29. Auffray C, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science. 2007;317(5838):666-670.
30. Ko S, et al. Bone marrow aplasia induced by passenger leukocytes from heart allografts. Exp Hematol. 2001;29(3):339-344.
31. León B, López-Bravo M, Ardavín C. Monocytederived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity. 2007;26(4):519-531.
32. +) dendritic cells for immune T cell areas. Cell. 2010;143(3):416-429.
33. Duffield JS, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005;115(1):56-65.
34. Kreisel D, et al. In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc Natl Acad Sci U S A. 2011;107(42):18073-18078.
35. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol. 2008;83(1):64-70.
36. Fox-Marsh A, Harrison LC. Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system. J Leukoc Biol. 2002;71(3):401-409.
37. Fox A, Mountford J, Braakhuis A, Harrison LC. Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection. J Immunol. 2001;166(3):2133-2140.
38. Barclay AN, van den Berg TK. The interaction between signal regulatory protein alpha (SIRPa) and CD47: structure, function, and therapeutic target. Annu Rev Immunol. 2014;32:25-50.
39. Takenaka K, et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol. 2007;8(12):1313-1323.
40. Wang H, Wu X, Wang Y, Oldenborg PA, Yang YG. CD47 is required for suppression of allograft rejection by donor-specific transfusion. J Immunol. 2010;184(7):3401-3407.
41. Majeti R, et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 2009;138(2):286-299.
42. Tseng D, et al. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proc Natl Acad Sci U S A. 2013;110(27):11103-11108.
43. Corry RJ, Winn HJ, Russel PS. Primarily vascularized allografts of hearts in mice: The role of H-2D, H-2K, and non H-2 antigens. Transplantation. 1973;16(4):343-350.
44. Camirand G, et al. Multiphoton intravital microscopy of the transplanted mouse kidney. Am J Transplant. 2011;11(10):2067-2074.
45. Oberbarnscheidt MH, et al. Memory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3. Transplantation. 2011;91(8):827-832.